ProCE Banner Activity

Meeting the Challenge: Transforming Patient Care in sHTG and FCS With Novel RNA-Based Therapies

Slideset

Expert-curated slides on the prevalence of severe hypertriglyceridemia (sHTG) and familial chylomicronemia (FCS), differentiating an sHTG vs FCS diagnosis, and how novel RNA-based therapies should be integrated into your practice. 

Released: March 24, 2025

Expiration: March 23, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by a grant from Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.